期刊文献+

HPLC法同时测定肠肽胶囊中三七皂苷R_1、人参皂苷Rg_1及Rb_1含量 被引量:1

Simultaneous Determination of Notoginsenoside R_1,Ginsenoside Rg_1 and Ginsenoside Rb_1 in Changtai Capsules by HPLC
暂未订购
导出
摘要 目的:建立肠肽胶囊中三七有效成分的HPLC含量测定方法。方法:色谱柱为SinoChrom ODS-BP(150 mm×4.6mm,5μm),以乙腈(A)和水(B)为流动相,梯度洗脱,检测波长为203 nm,流速为1.0 ml·min^(-1),柱温为室温,进样量为20μl。结果:三七皂苷R_1、人参皂苷Rg_1及人参皂苷Rb_1的线性范围依次为63.9~319.5μg·ml^(-1)、112.6~563.2μg·ml^(-1)、102.5~512.8μg·ml^(-1),线性关系良好(r值分别为0.999 7、0.999 4、0.999 9);三种皂苷的平均回收率分别为96.47%、98.75%,97.55%,RSD分别为1.52%、1.73%、1.81%(n=6)。结论:本方法简便可行、准确、灵敏度高、专属性强,可用于肠肽胶囊的质量控制。 Objective: To develop an HPLC method for the simultaneous determination of active ingredients in Changtai capsules. Method: The HPLC method was carried out on a SinoChrom ODS-BP column ( 150 mm × 4. 6 mm,5 μm) at room temperature. The mobile phase consisted of acetonitrile (A)-water (B) with gradient elution, the flow rate was 1.0 ml·min^-1, the UV detection wavelength was at 203 nm and the injection volume was 20 μl. Result: The calibration curves showed good linear correlation within the range of 63.9-319. 5 μg·ml^-1 for Notoginsenoside R1 (r =0. 999 7) ,112. 6-563.2 μg·ml^-1 for Ginsenoside Rg1 (r =0. 999 4) and 102. 5-512. 8 μg· ml^-1 for Ginsenoside Rb1 (r = 0. 999 9). The average recovery of Notoginsenoside Rl , Ginsenoside Rg1 and Ginsenoside Rbl was 96. 47% with RSD of 1.52% ,98.75% with RSD of 1.73% and 97.55% with RSD of 1.81% ,respectively. Conclu sion: The method is simple, feasible,precise, sensitive and strongly specific, and can be used for the quality control of Changtai capsules.
出处 《中国药师》 CAS 2011年第10期1447-1449,共3页 China Pharmacist
关键词 肠肽胶囊 三七皂苷R1 人参皂苷RG1 人参皂苷RB1 高效液相色谱法 含量测定 Changtai capsules Notoginsenoside R1 Ginsenoside Rg1 Ginsenoside Rb1 HPLC Determination
  • 相关文献

参考文献7

二级参考文献19

  • 1钱越洲,刘宇,顾仁樾.三七有效成分Rx对离体心脏缺血再灌注损伤的影响[J].上海中医药大学学报,2005,19(1):50-52. 被引量:10
  • 2顾国嵘,黄培志,童朝阳,葛均波,姚晨玲,施东伟,樊帆.血塞通预处理对心肌缺血再灌注损伤的早期保护作用[J].中国急救医学,2005,25(4):264-265. 被引量:22
  • 3冯亮,蒋学华,叶利民.三七总皂苷中各组分含量测定方法的改进[J].华西药学杂志,2006,21(2):187-189. 被引量:15
  • 4周志华 章观德 等.三七中皂甙成分分析的研究[J].药学学报,1981,16(7):535-535.
  • 5卫生部药品标准[S]中药成方制剂.第十八册.1998.30-32.
  • 6Ping Z, Yu Q L, Chong R Y. Minor dammarrane saponins from Panax notoginseng [J]. Phytochemistry , 1996, 41(5):1419-1422.
  • 7Wei G M, Massanori M, Karl E M, et al. Saponins from the roots of Panax notoginseng [J]. Phytochemistry, 1999, 52:1133-1139.
  • 8Wang M, Fan Y G, Gao W F. Quantitative determination of notoginsenoside R1, and ginsenosides Rg1, Rb1 content in total notoginsenoside of Panax notoginseng and Xuesaitong Injection by HPLC gradient elution method [J]. Chin J Pharm Anal(药物分析杂志),2000,
  • 9.中国药典[S]一部[M].,2005年版.6.
  • 10中国药典2005年版一部[S].2005:281.

共引文献484

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部